News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Zymeworks Appoints Antibody and Drug Development Expert Dr. Paul J. Carter to its Scientific Advisory Board


4/14/2009 9:39:57 AM

VANCOUVER--(BUSINESS WIRE)--Zymeworks Inc., a privately held computational biotechnology company, today announced the appointment of Dr. Paul J. Carter, Chief Scientific Officer of VLST Corp., to its scientific advisory board.

Read at BioSpace.com

comments powered by Disqus
Zymeworks
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES